RPG Life Sciences (RPGLIFE) — Announcement

1 Announcement 🔴 High Importance Neutral 📄 PDF

📢 Key Event
RPG Active Pharma to acquire Raghava Life Sciences' API business for up to ₹135 crores

🔄 What Changed
Added 300 KL capacity and 22 commercialized APIs to RPGAP's portfolio

🔮 What's Next
The acquisition will be funded in line with the recent equity raise announced by RPGAP

💡 Investor Takeaway
This acquisition expands RPGAP's API scale and growth potential through added capacity and product portfolio.

RPG Life Sciences announced that its subsidiary RPG Active Pharma Limited will acquire Raghava Life Sciences' API and intermediates business for up to ₹135 crores via slump sale, adding 300 KL of EU-GMP approved capacity and 22 commercialized APIs to strengthen its integrated API strategy and market position.

2 Announcement 🔴 High Importance Neutral 📄 PDF

📢 Key Event
RPG Life Sciences to separate API business into new subsidiary RPGAP and acquire Actis Generics and Raghava Life Sciences

🔄 What Changed
API business transferred to RPGAP via slump sale; 60% stake in RPGAP issued to InvAscent; two acquisitions completed

🔮 What's Next
Closing of investment and agreements upon shareholder approval

💡 Investor Takeaway
Shareholders gain exposure to a focused API growth strategy with strategic PE partnership and expanded product portfolio.

RPG Life Sciences announced its plan to separate the API business into a new subsidiary, RPGAP, and secure strategic investment from InvAscent PE, acquiring Actis Generics and Raghava Life Sciences to expand capacity and product portfolio, while maintaining zero debt and strong liquidity for future growth.

📊 Stock Analysis — RPGLIFE ✨ Ask AI About This

About RPG Life Sciences Ltd (RPGLIFE)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹4,456.85 Cr P/E: 37.3 ROE: 19.8% ROCE: 25.8% Div Yield: 0.89%

View full RPGLIFE stock details →

📡 Get AI alerts when RPGLIFE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track RPGLIFE — Free

💡 Ask AI about this filing

"How will the ₹135 crore acquisition be financed?" "What synergies are expected from integrating Raghava's API portfolio?" "When will regulatory approvals be secured for the deal?"

Ask AI Free →

📊 More RPGLIFE filings

See all RPGLIFE filings →

🔥 Also filed on 2 September 2026

WAAREEENER Waaree Energies Ltd Annual Report PEARLPOLY Pearl Polymers Ltd Annual Report 544627 Purple Wave Infocom Ltd Annual Report 544437 Marc Loire Fashions Ltd Annual Report RTNINDIA RattanIndia Enterprises Ltd Annual Report 544596 Safecure Services Ltd Annual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when RPGLIFE files new disclosures

Track RPGLIFE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track RPGLIFE — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd

RPG Life Sciences Ltd (RPGLIFE) — Announcement | 2 September 2026(2 announcements)

About RPG Life Sciences Ltd (RPGLIFE)

📡 Get AI alerts when RPGLIFE files next

💡 Ask AI about this filing

📊 More RPGLIFE filings

🔥 Also filed on 2 September 2026